Why has customer satisfaction for IQVIA's Clinical Trial Optimization services declined by 20% compared to last year's ratings?

Introduction

The 20% decline in customer satisfaction for IQVIA's Clinical Trial Optimization services compared to last year's ratings is a significant issue that requires immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a specific event or change that triggered this decline. Has there been any major product update or service change in the past year?

Why it matters: Identifying a specific trigger point can help narrow down the root cause. Expected answer: Yes, there was a significant update to the optimization algorithm. Impact on approach: If confirmed, we'd focus on the impact of this update on user experience and results.

• Considering the scale of the decline, I'm wondering if this affects all customer segments equally. Have you noticed any patterns in the satisfaction decline across different customer types or trial sizes?

Why it matters: Understanding if the issue is universal or segment-specific will guide our investigation and solution design. Expected answer: The decline is more pronounced among smaller biotech companies. Impact on approach: We'd need to investigate why smaller companies are more affected and tailor solutions accordingly.

• Given the nature of clinical trials, I'm curious about the timeline of this decline. Has this been a gradual decrease over the year, or was there a sudden drop at some point?

Why it matters: The pattern of decline can indicate whether it's due to a specific event or a gradual deterioration of service quality. Expected answer: There was a sharp decline about six months ago, followed by a plateau. Impact on approach: We'd focus on events or changes that occurred around that six-month mark.

• Considering the complexity of clinical trial optimization, I'm thinking about changes in the competitive landscape. Have there been any significant moves by competitors or new entrants in the market over the past year?

Why it matters: External factors could be influencing customer perception and expectations. Expected answer: A new competitor entered with an AI-driven optimization tool. Impact on approach: We'd need to assess our product's competitiveness and possibly accelerate our innovation roadmap.